Skip to content

FLSC FRAZIER LIFE SCIENCES ACQ-A

Follow

Class A Ordinary Shares, par value $0.0001 per share (common), issuer CIK 2153598

No 13F filer reports this security in the loaded quarters.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

Events

  • Venrock Healthcare Capital Partners III, L.P. and 6 other reporting persons reported 700,000 FLSC shares, 9% of the class, as of 2026-10-15, in a 13G filed 2026-10-27. 0001738048-26-000075

    Accepted , ingested
  • RA CAPITAL MANAGEMENT, L.P. and 3 other reporting persons reported 700,000 FLSC shares, 9% of the class, as of 2026-10-15, in a 13G filed 2026-10-22. 0001346824-26-000245

    Accepted , ingested
  • Frazier Life Sciences Holdings II LLC and 4 other reporting persons reported 1,983,749 FLSC shares, 20.5% of the class, as of 2026-10-15, in a 13D filed 2026-10-21. 0001193125-26-428005

    Accepted , ingested
  • BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 500,000 FLSC shares, 6.4% of the class, as of 2026-10-14, in a 13G filed 2026-10-21. 0000921895-26-002836

    Accepted , ingested
  • Deep Track Capital, LP and 3 other reporting persons reported 700,000 FLSC shares, 8.97% of the class, as of 2026-10-14, in a 13G filed 2026-10-21. 0001172661-26-004630

    Accepted , ingested
  • Coastlands Capital LP and 4 other reporting persons reported 500,000 FLSC shares, 6.41% of the class, as of 2026-10-15, in a 13G filed 2026-10-16. 0001104659-26-116496

    Accepted , ingested